Diethylamine

Diethylamine

SCHEMBL556784

CCNCC.Cc1ccc(C(c2ccccc2C)c2ccccc2C)cc1

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CCKAR

The experimentally established mechanism targets of Diethylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
ESR1 P03372 1/20 0.37
CNR1 P21554 2/20 0.36
CNR2 P34972 2/20 0.36
CYP2D6 P10635 3/20 0.35
CYP3A4 P08684 2/20 0.35
SLC6A2 P23975 2/20 0.35
SLC6A4 P31645 2/20 0.35
SLC6A3 Q01959 2/20 0.35
KCNH2 Q12809 2/20 0.35
ACP3 P15309 1/20 0.33
DRD3 P35462 2/20 0.33
LMNA P02545 2/20 0.33
SLC22A2 O15244 1/20 0.33
SLC22A1 O15245 1/20 0.33
GRIN2D O15399 1/20 0.33
GRIN3B O60391 1/20 0.33
CHRM2 P08172 1/20 0.33
CHRM4 P08173 1/20 0.33
CHRM5 P08912 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diethylamine SCHEMBL11318959 0.95 ESR1 (0.41) ALDH1A1ESR1CYP2D6CYP3A4SLC6A2
Diethylamine SCHEMBL6512053 0.89 ACP3 (0.42) ESR1CYP2D6CYP3A4SLC6A2SLC6A4
Diethylamine SCHEMBL8165175 0.89 ACP3 (0.42) ESR1CYP2D6CYP3A4SLC6A2SLC6A4
Diethylamine SCHEMBL4185484 0.86 ACP3 (0.42) ESR1CYP2D6CYP3A4SLC6A2SLC6A4
Diethylamine SCHEMBL6365629 0.85 ESR1 (0.45) ALDH1A1ESR1CYP2D6CYP3A4SLC6A2
Diethylamine SCHEMBL10775399 0.84 ALDH1A1 (0.43) ALDH1A1ESR1CNR2ACP3OPRM1
Diethylamine SCHEMBL237985 0.83 ESR1 (0.43) ALDH1A1ESR1CYP2D6CYP3A4SLC6A2
Diethylamine SCHEMBL10780343 0.82 ESR1 (0.42) ALDH1A1ESR1CYP2D6CYP3A4SLC6A2
Diethylamine SCHEMBL10778585 0.78 HTT (0.41) ALDH1A1ESR1SLC6A4KCNH2LMNA
Diethylamine SCHEMBL6271332 0.77 ESR1 (0.45) ALDH1A1ESR1CYP2D6CYP3A4SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0119755-B1 SENSITIZED PHOTOCONDUCTIVE COMPOSITIONS AND ELEMENTS EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1987-12-02 EP claimed
EP-0119755-A2 Sensitized photoconductive compositions and elements EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1984-09-26 EP claimed
US-4468444-A Pyrylium-sensitized leuco base photoconductive compositions and elements containing naphthalene bis-dicarboximide compounds EASTMAN KODAK COMPANY (US) 1984-08-28 US claimed
US-4442193-A SENSITIZED TO RADIATION BELOW 400 NANOMETERS EASTMAN KODAK COMPANY (US) 1984-04-10 US claimed
EP-0011980-B1 PHOTOCONDUCTIVE LAYERS CONTAINING A MIXTURE OF AT LEAST TWO DIFFERENT ORGANIC PHOTOCONDUCTORS AND ELECTROPHOTOGRAPHIC ELEMENTS COMPRISING SAID LAYERS EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1984-03-28 EP claimed
EP-0011980-A1 Photoconductive layers containing a mixture of at least two different organic photoconductors and electrophotographic elements comprising said layers EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1980-06-11 EP claimed
US-20220112996-A1 JEWELRY AND GEM STONE LIGHTING SYSTEMS AND APPARATUSES AND METHOD MAKING AND USING SAME ASHLEY PAUL (US) 2022-04-14 US disclosed
US-11018303-B2 Charge-transporting varnish NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2021-05-25 US disclosed
EP-3053910-B1 ANILINE DERIVATIVES AND USES THEREOF NISSAN CHEMICAL CORP (JP) 2021-04-28 EP disclosed
EP-3109914-B1 CHARGE-TRANSPORTING VARNISH NISSAN CHEMICAL CORP (JP) 2021-04-28 EP disclosed
US-20210078934-A1 CHARGE-TRANSPORTING VARNISH NISSAN CHEMICAL CORPORATION (JP) 2021-03-18 US disclosed
US-20210061825-A1 ANILINE DERIVATIVE AND USE THEREOF NISSAN CHEMICAL CORPORATION (JP) 2021-03-04 US disclosed
EP-3766887-A1 ANILINE DERIVATIVE AND USE THEREOF Nissan Chemical Corporation (JP) 2021-01-20 EP disclosed
US-4686163-A Electrophotographic color imaging method EASTMAN KODAK COMPANY (US) 1987-08-11 US disclosed
US-4600669-A Electrophotographic color proofing element and method for using the same EASTMAN KODAK COMPANY (US) 1986-07-15 US disclosed
EP-0186172-A1 Electrophotographic color proofing method EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1986-07-02 EP disclosed
EP-0119755-A2 Sensitized photoconductive compositions and elements EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1984-09-26 EP disclosed
US-4468444-A Pyrylium-sensitized leuco base photoconductive compositions and elements containing naphthalene bis-dicarboximide compounds EASTMAN KODAK COMPANY (US) 1984-08-28 US disclosed
US-4442193-A SENSITIZED TO RADIATION BELOW 400 NANOMETERS EASTMAN KODAK COMPANY (US) 1984-04-10 US disclosed
EP-0011980-B1 PHOTOCONDUCTIVE LAYERS CONTAINING A MIXTURE OF AT LEAST TWO DIFFERENT ORGANIC PHOTOCONDUCTORS AND ELECTROPHOTOGRAPHIC ELEMENTS COMPRISING SAID LAYERS EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1984-03-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210061825-A1 ANILINE DERIVATIVE AND USE THEREOF NAT1, DRD3, AR ALDH1A1 349/4885ESR1 898/4885CNR1 216/4885
US-20210078934-A1 CHARGE-TRANSPORTING VARNISH SLC43A1, SLC7A5, SLC38A7 ALDH1A1 967/4885ESR1 1912/4885CNR1 2090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.